- Tags: cornea
Pipeline
OKYO Pharma reports favorable phase 2 data for NCP asset
Formerly OK-101, urcosimod is formulated for topical application, with latest results demonstrating a favorable impact on corneal nerve health.
Pipeline
EyeYon Medical secures IDE approval for study on first artificial endothelial layer
IDE approval allows for clinical study initiation to evaluate EndoArt, the first-ever synthetic implant for treating corneal edema and improving vision.
Pipeline
Precise Bio performs first transplant with 3D-printed cornea implant
Procedure deemed successful in treating first fully blind patient using corneal bio-implant made from corneal endothelial cells.
Research
Study identifies key vitamin supplementation for NCP
Vitamins B3, 12, and D may offer new therapeutic approaches to neuropathic corneal pain management.
Research
Nearly 50% of adults with keratoconus still facing high rate of progression
Study finds, across all age groups, patients with advanced disease were most at risk of keratoconus progression.
Research
Study: BioTissue's CAM improves recovery following corneal CXL
Research from AAO supports BioTissue’s Prokera as an FDA-cleared therapeutic device for use following epi-off CXL among keratoconus patients.
Business
Verséa Ophthalmics relaunches as DefEYE Inc
Ophthalmic biologics company makes official debut with the exclusive U.S. commercial rights to the BIOVANCE franchise of decellularized biologics.
Pipeline
Kala's phase 2b PCED trial fails to meet primary goal
Company plans to cease development of lead asset KPI-012 as the CHASE study also falls short of achieving statistical significance for secondary endpoints.
Research
Are corneal dystrophies linked to mental health conditions?
Study highlights the importance of assessing corneal dystrophy patients’ psychological well-being.
Products
FDA reportedly clears Moria Surgical's corneal storage solution
XTRA4 is designed to preserve refrigerated human donor corneas for up to 14 days—reducing risk for graft detachments and improving availability for corneal transplant patients.
Products
Unique anterior stromal puncture device targets RCEs
VEO Ophthalmics and Plexitome Medical’s partnership includes commerical launch of a new ASP method that allows treatment in the optical axis—without scarring.
Products
Ziemer USA unveils new CTAK module for GALILEI diagnostic platform
Latest addition to the FDA-cleared diagnostic device combines high-resolution corneal tomography with laser-guided stromal inlay preparation for customized corneal reshaping.
Products
Haag-Streit launches corneal map for the Lenstar 900
The optical biometer’s newest integratable feature enables simultaneous measurement of a wider range of biometric parameters for cataract surgery planning.
Pipeline
Allotex submits IDE to FDA for collagen-based corneal implant
Company is seeking to conduct a U.S. clinical trial on its tissue addition technology procedure that augments the cornea using precision-shaped human collagen.
Research
ADHD medication may lead to corneal cell changes in pediatric patients
Study notes differences in key parameters of corneal and retinal health in patients taking methylphenidate.
Business
Allotex names new CEO to lead commercialization of allogeneic corneal tissue technology
Co-founder Michael Mrochen, PhD, will assume leadership as the startup seeks an IDE for its biocompatible procedure for vision correction.
Products
B+L launches Zenlens CHROMA HOA scleral contact lenses
Newest addition to the scleral lens brand features a custom-designed, wavefront-guided scleral lens technology intended to correct advanced HOA.
Research
Could a CXL and customized PRK combo provide better keratoconus outcomes?
Literature review finds combined procedure provides superior visual acuity and quality.
Pipeline
FDA grants Fast Track designation to OKYO Pharma's NCP therapeutic
New status gives urcosimod an expedited pathway toward potential market approval as first approved treatment for this patient base.
Business